Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin in the Treatment of Cocaine Use Disorder

Hendricks Peter S., Lappan Sara N., Shelton Richard C., Lahti Adrienne C., Cropsey Karen L., Johnson Matthew W., Bradley Melissa, Simonsson Otto, Davis Lori L., Grossman Daniel H., Ortiz Cynthia E.

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (46)

  1. Psilocybin or Nicotine Patch for Smoking Cessation 2026-03-10 · Expand citations
  2. Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial. 2025-07-24 · Expand citations
  3. Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis. 2025-07-01 · Expand citations
  4. Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis. 2024-08-21 · Expand citations
  5. Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression. 2024-06-01 · Expand citations
  6. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. 2023-09-05 · Expand citations
  7. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
  8. Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. 2022-10-01 · Expand citations
  9. Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations. 2022-08-15 · Expand citations
  10. Blinding and expectancy confounds in psychedelic randomized controlled trials. 2021-09-01 · Expand citations
  11. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. 2020-10-01 · Expand citations
  12. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  13. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  14. 10.1001/archpsyc.1973.01750360040005
  15. 10.1001/jama.2022.0395
  16. 10.1001/jamanetworkopen.2021.8049
  17. 10.1001/jamapsychiatry.2025.0085
  18. 10.1002/sim.1047
  19. 10.1007/s11606-019-05074-8
  20. 10.1007/s40732-017-0236-1
  21. 10.1016/j.drugalcdep.2010.11.004
  22. 10.1016/j.eclinm.2025.103149
  23. 10.1016/j.phrs.2024.107454
  24. 10.1016/s0005-7916(00)00012-4
  25. 10.1016/s2215-0366(23)00095-0
  26. 10.1037/0022-006x.59.4.526
  27. 10.1037/0022-006x.67.1.37
  28. 10.1037/0022-006x.68.3.515
  29. 10.1038/s41598-025-14895-z
  30. 10.1038/s44220-025-00417-3
  31. 10.1046/j.1360-0443.1995.9056072.x
  32. 10.1080/10543401003777995
  33. 10.1097/00001648-199001000-00010
  34. 10.1111/add.13327
  35. 10.1111/add.16200
  36. 10.1111/add.16529
  37. 10.1111/j.1360-0443.2004.00743.x
  38. 10.1111/j.1360-0443.2009.02879.x
  39. 10.1136/bmj-2024-081123
  40. 10.1136/bmj.316.7139.1236
  41. 10.1136/bmj.l6802
  42. 10.1176/appi.ajp.20250053
  43. 10.1177/0269881112439253
  44. 10.1186/s12991-015-0063-1
  45. 10.1371/journal.pone.0266142
  46. 10.2147/clep.s161508

Cited by — these papers cite this paper (2)

  1. Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA 2026-06-15 · Expand citations
  2. Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder-A Critical Appraisal 2026-05-07 · Expand citations